{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:38:10Z","timestamp":1791275890351,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.leukres.2011.08.016","type":"journal-article","created":{"date-parts":[[2011,9,15]],"date-time":"2011-09-15T09:50:52Z","timestamp":1316080252000},"source":"Crossref","is-referenced-by-count":19,"title":["Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS"],"prefix":"10.1016","author":[{"given":"Peter","family":"Valent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Bain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Wimazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang R.","family":"Sperr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghulam","family":"Mufti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Horny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2011.08.016_bib0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2011.08.016_bib0010","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/10245330512331390311","article-title":"The myelodysplastic syndromes: diagnosis, molecular biology and risk assessment","volume":"10","author":"Bennett","year":"2005","journal-title":"Hematology"},{"key":"10.1016\/j.leukres.2011.08.016_bib0015","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1182\/blood-2007-08-078139","article-title":"Myelodysplastic syndromes","volume":"111","author":"Nimer","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.08.016_bib0020","first-page":"88","article-title":"Myelodysplastic syndromes\/neoplasms","volume":"2","author":"Brunning","year":"2008"},{"key":"10.1016\/j.leukres.2011.08.016_bib0025","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1309\/AJCPRCXX4R0YHKWV","article-title":"Myelodysplastic syndromes","volume":"132","author":"Orazi","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.leukres.2011.08.016_bib0030","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.leukres.2006.11.009","article-title":"Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference","volume":"31","author":"Valent","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2011.08.016_bib0035","series-title":"Satellite symposium: an evolution in the understanding of myelodysplastic syndromes, European Society for Hematology June 15","article-title":"Problems in the morphological diagnosis of MDS","author":"Bain","year":"2006"},{"key":"10.1016\/j.leukres.2011.08.016_bib0040","series-title":"Paper presented at the 9th international symposium on myelodysplastic syndromes","article-title":"Minimal diagnostic criteria and differential diagnosis of MDS: IWGM-MDS consensus proposal for identification of idiopathic cytopenia of uncertain significance (ICUS)","author":"Mufti","year":"2007"},{"key":"10.1016\/j.leukres.2011.08.016_bib0045","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3324\/haematol.2009.005801","article-title":"Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes","volume":"94","author":"van de Loosdrecht","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2011.08.016_bib0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000101709","article-title":"Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic\/myeloproliferative diseases","volume":"74","author":"Orazi","year":"2007","journal-title":"Pathobiology"},{"key":"10.1016\/j.leukres.2011.08.016_bib0055","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.leukres.2007.05.010","article-title":"Diagnostic value of histology and immunohistochemistry in myelodysplastic syndromes","volume":"31","author":"Horny","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2011.08.016_bib0060","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3324\/haematol.13755","article-title":"Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach","volume":"94","author":"Bennett","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2011.08.016_bib0065","doi-asserted-by":"crossref","first-page":"483","DOI":"10.18632\/oncotarget.185","article-title":"Standards and impact of hematopathology in myelodysplastic syndromes (MDS)","volume":"1","author":"Valent","year":"2010","journal-title":"Oncotarget"},{"key":"10.1016\/j.leukres.2011.08.016_bib0070","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.leukres.2007.03.015","article-title":"Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface","volume":"31","author":"Wimazal","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2011.08.016_bib0075","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2362.2009.02151.x","article-title":"Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions","volume":"39","author":"Valent","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.leukres.2011.08.016_bib0080","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1093\/annonc\/mdq233","article-title":"Distinguishing myelodysplastic syndromes (MDS) from idiopathic cytopenia of undetermined significance (ICUS): HUMARA unravels clonality in a subgroup of patients","volume":"21","author":"Schroeder","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.leukres.2011.08.016_bib0085","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2141.2010.08257.x","article-title":"PNH-phenotype cells in patients with idiopathic cytopenia of undetermined significance (ICUS) with megakaryocytic hypoplasia and thrombocytopenia","volume":"150","author":"Ando","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2011.08.016_bib0090","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.leukres.2008.02.022","article-title":"Low erythropoietin production as non-oncogenic co-factor contributing to disease-manifestation in low-risk MDS: a hypothesis supported by unique case reports","volume":"32","author":"Valent","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2011.08.016_bib0095","first-page":"531","article-title":"Idiopathic bone marrow dysplasia of unknown significance (IDUS): definition, pathogenesis, follow up, and prognosis","volume":"1","author":"Valent","year":"2011","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.leukres.2011.08.016_bib0100","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.leukres.2003.10.023","article-title":"Normal bone marrow function over 6 years in a patient with dysplastic hematopoiesis and a complex karyotype","volume":"28","author":"Valent","year":"2004","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2011.08.016_bib0105","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2141.2007.06502.x","article-title":"Unexplained anaemia in older persons is characterised by low erythropoietin and low levels of pro-inflammatory markers","volume":"136","author":"Ferrucci","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2011.08.016_bib0110","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1365-2362.2008.02013.x","article-title":"Anaemia of the elderly (AOE): does it exist and does it matter in clinical practice?","volume":"38","author":"Valent","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.leukres.2011.08.016_bib0115","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.1365-2141.1997.4013211.x","article-title":"Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model","volume":"99","author":"Hellstr\u00f6m-Lindberg","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2011.08.016_bib0120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1053\/j.seminhematol.2007.10.004","article-title":"Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes","volume":"45","author":"Hellstr\u00f6m-Lindberg","year":"2008","journal-title":"Semin Hematol"},{"key":"10.1016\/j.leukres.2011.08.016_bib0125","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1182\/blood-2009-08-239749","article-title":"Aberrant immunophenotype of blasts in myelodysplastic syndromes is a clinically relevant biomarker in predicting response to growth factor treatment","volume":"115","author":"Westers","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.08.016_bib0130","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611004164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611004164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T22:32:23Z","timestamp":1592951543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212611004164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":26,"alternative-id":["S0145212611004164"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2011.08.016","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}